The STING pathway promotes interferon (IFN) response and is integral in the recruitment of T-cells and NK-cells (54). A retrospective cohort study analyzed MET copy number and STING levels in patients previously diagnosed with NSCLC. This evidence concerns the gene STING1 and non-small cell lung carcinoma.